`
`09/08/201 7
`
`PATENT ASSIGNMENT COVER SHEET
`
`Electronic Version v1.1
`Stylesheet Version v1.2
`
`EPAS ID: PAT4585621
`
`
`SUBMISSION TYPE:
`NEW ASSIGNMENT
`
`
`NATURE OF CONVEYANCE:
`ASSIGNMENT
`
`CONVEYING PARTY DATA
`
`ALLERGAN, INC.
`
`RECEIVING PARTY DATA
`
`09/08/2017
`
`m SAINT REGIS MOHAWK TRIBE
`Street Address:
`412 STATE ROUTE 37
`
`
`City:
`AKWESASNE
`
`NEW YORK
`State/Country:
`13655
`Postal Code:
`
`
`PROPERTY NUMBERS Total: 6
`
`
`Property Type
`Number
`
`8633162
`Patent Number:
`
`
`
`
`
`
`Patent Number: 8648048
`
`
`
`Patent Number:
`
`8685930
`
`9248191
`Patent Number:
`
`
`CORRESPONDENCE DATA
`
`(714)246—4249
`Fax Number:
`Correspondence will be sent to the e-mail address first; if that is unsuccessful, it will be sent
`using a fax number, if provided; if that is unsuccessful, it will be sent Via US Mail.
`Phone:
`714-246-4500
`
`Email:
`Correspondent Name:
`Address Line 1:
`Address Line 4:
`
`patentsiip@allergan.com
`ALLERGAN, INC.
`2525 DUPONT DRIVE, T2—7H
`IRVINE, CALIFORNIA 92612—1599
`
`ATTORNEY DOCKET NUMBER:
`
`17618
`
`
`NAME OF SUBMITTER:
`LAURA L. WINE
`
`
`SIGNATURE:
`/Laura L. Wine/
`
`DATE SIGNED:
`
`09/08/2017
`
`Total Attachments: 6
`
`504538914
`
`PATENT
`REEL: 043532 FRAME: 0422
`
`SRMT 2103 - Pg. 1
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01 129
`
`SRMT 2103 - Pg. 1
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01129
`
`
`
`source=Short form-Patent Assignment - Signed#page1.tif
`source=Short form-Patent Assignment - Signed#page2.tif
`source=Short form-Patent Assignment - Signed#page3.tif
`source=Short form-Patent Assignment - Signed#page4.tif
`source=Short form-Patent Assignment - Signed#pag95.tif
`
`source=Short form—Patent Assignment — Signed#page6.tif
`
`PATENT
`REEL: 043532 FRAME: 0423
`
`SRMT 2103 - Pg. 2
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01 129
`
`SRMT 2103 - Pg. 2
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01129
`
`
`
`EXECIZITIQ " IEKSIGN
`
`SHORT KERN! §ATEP€T A$SIGF€MENT
`
`This Pawn: Assignmsm {this “Assignment? i5 mafia a3 {If Swimwear E‘s, 269i?
`{mach time, the: "Efi‘ect‘aw Data”), by am bahwsn faiiaza‘gma, has; a fleiawzaas coagmaasama
`{“Assigxmrfi and Sam Ragis Mahawk ‘Txibaa‘ a feaieraiiyamsatagniwd mvemign Native:
`Ameaiaaaata Tram {“Assiguw‘fia
`
`WHEREAS, Assagmr was 1312 patients emai gamma apg‘aiimticias SSE farm in
`Mackinaw! A {the ‘“§’aa€aaaat§“ja;
`
`WHEREAS) Assigmar dassa‘a‘es m asgigaa, mansfksay 8:3;va and aisli‘aaea‘ as
`Assignee; and Ass‘agfiefi Wis-has m acqaaa’aaza fauna Assigmn aii a)?” iés aigixé’, aifle and Waves; in, {a}
`and under aha Patemss; and
`
`WHEREASa pursuant ts: ami £2903 the terms, {3in mamas» mad mafiiticns oi; the
`Patent Assigaamcm figmemeaaa aimed as If Sagatfimber 3, 3:31? was: “Lang Ema Agreamasnfl!
`Isa}! mi heawaaen Assigmr 2am Assigaaem s‘assigaaoa desia'es to wnfirm amai yeafeqt its assaignmena,
`33:22am; mma‘fiygaaw and (flailiwry to Amigame 3f gel} azaf its right, Eitk: amai imam-:3: In, an anti
`maxim file: Famms and 31a,
`is} ami waiter the: ixwismimas rammswmd iharehy, ami Asségm‘c is
`dwimus m‘f wafimia‘ag and yerfmzamg ti’m 3mm.
`
`NGW5 Ti-IEREFQRE, for gmai and vaiuzahie maasidfimtiam, aha messigt am
`sufficienaty a?“ wh‘ach are: Eaamaby‘ aeka‘mwiedgmi, Em: mamas Imam immding Eat: he: iegafiy
`hammi hemiay Engage as fafiaws:
`
`Ia Amaggagawm As: {if the Effmtiva: Date, Assi‘jamr harem wave-33, irazasfaaa‘s, assigns
`aaaai defines-s m Assigaam and Aggigaase Eaaamby gamma the from Aasfigma, an sf
`Assagmaka right aétie am magma: as: m and under aha Paaems, aogazahgr with my
`missuzsa rascxamnmmm, davisiamaaa aezatimamiom‘ somtia‘auaatiamsaéaawpm, <2:m:a:*a3iamasw axed
`{WEE-W ads a?" smash Assigned i’aimts aaIratady ga‘gnaeai and whack may he: gi‘amteai {karma
`T313 assaigfimem attaratcmpimcci bargain i3 mam: ta be: an ahsaime assaaiglm‘amt am? mt hy
`may of 329mb}-
`
`g»;
`
`figfiil akasurances As may as nacaassaarya Assigmr shall exacaatfia afikaaaawiséga: and
`(waver such ether iaasatmmm‘as, dmaamma‘g mad ggmemems and Shani: do sash cake:
`flag as may be magsagmahiy nexessaay garage: or advisahiaa ta) earry 0m: fig cabiigaaioaas
`anaifir this. Agageaaaem' anti as may he a‘easmaab‘w mwasa‘mfia‘ pmpsr 9r adviszfiaia: {a more
`mmnIattazIy afiarctime.
`floa‘aa‘aamaamta
`remaai perfect
`tar canfiam {I‘m :3mmctionas
`maifimyfiamé haxfisya
`
`3 Rama‘datim. The Awigmaa“ harem aaat‘hmizaas the magma: of Panama‘s and 'i‘maammrks
`iaa figs {Suited Siam Fatwa and demma’k {affise {a} award Amigaaee as the assigns
`and name: of that Assigmxl Paaaaaats anai to aieiivaa‘ to Asaaégraca‘z, 33¢ {a MSa‘gfiaae‘s
`ataaramegaas‘ agents, gaaaraessea‘s aaa‘ aassigazaaa, an (afiicaai documaaaats 2am: cmmmmieatiatsais as
`may be: warmmai by 313:; Aaqs‘agmzaang aaachadéaag but not limilmi t0 igm’mg any and all
`Lama‘s E’amfis Of @123: {faitéé Saws 9:: invenmnsa céaaa‘amd 5:32 the Famam
`
`
`4a SFJngfigjgggfiy '
`:g3f3fgggagiggjflmggigi. Asatigaafie a‘egaamseaxm {hat it 313a: my! anti wiii
`mt waive its safefi'era‘igzn immunity car
`{1‘15 smemign immunity {if any Cvmngasany,
`caugxamiim caaaasaprisa‘:
`au‘aiaaaa‘aay fia‘visima‘
`fiaabaiivisian, ham-5&1 9r athar agmmyv
`ixastmneaataiiay as: {3th gmmamem wmmneafi (a? ASsignse {mafia {3f 33% {wagging» a
`
`'v't/"a{73% REEI.
`
`(,
`
`M11
`
`SRMT 2103 - Pg. 3
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01 129
`
`SRMT 2103 - Pg. 3
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01129
`
`
`
`ix; was}: cage, in mimim in my Enter panes
`imiudifig Asségme, a ""Frihal 3.3mm”),
`mviaw fix“ any other pmmeding in the, {Emmi States Patent £2: '"fmdemark Officfi a): any
`afiminismm‘e pmcmxfiing that may he flied far ‘Ehi: panama m“ invsfiaiatmg 9r rmdming
`uneufmmahie any Agsignfisd E’aaenm. 250; garpuges 9f thia Asmignmm: Agrgaemem. m3
`pmvésimz {if this Assiigmmm Agrezsmgm simuki 32:2: mtemmicé is: mnsiimta & waiver a?“
`ASSigszeés’s mt may ether Tribai i-‘axrijfifi sawmigm immunity as Ea any imr pémas mvicw
`m sémifar pmaeaufizzgés.
`
`i
`
`figfixggfimfizgfi A'ssigmr ami Assigme gash ackmwiadgfi and agrm this: the
`i‘cgiresesxmfims, waré‘émtiea mwmmis, ahligatiesxiz and mixer terms mistaineii in 3316:
`{mag Fem Agremnm! ghaii mi 33:: satpfimeziad hembys but $113.3} ramain in 52.312 fame
`mid cfi‘ect m fihfi‘: Suki Miami gresvifimi therein, "$0 the extem m: as}! prawiaim at“ this
`Assigfiment fig incmsmcm m" canfiicts with the Long Farm Agmemem, the §zmvi§ims
`affine Long Form Agmemem shaii unmet 'Z‘he partigs may enema M3 Agsigm‘nem
`in muhépia catamarans, my me (pf wkiafiz maxi 530: (imam the figmmm csf mere: than
`some party, but aii swath mummpam taken mgmfiax 33m}! wastimir: am: and the same:
`inmumam Any mumerpam may be: axecuteii hy fagsimiig gr H3? sigmaime and such
`é‘aca‘imiic (2: FE)? sigmtm 9213:: be damefi am mgfmi. Time {ms and mmfitims {in}?
`this Asaignmem shaii fire Wading; 133mm 12:: pam‘gs {mete am: their mapsefim same-35013
`ami RSSigfiS, This Assigmmn: shali be gowmed E3}! and camsmsed in awofiiaams with
`the: iaw 9f the Stage 0.? Naw Yam without givifig effect to the pziucipies <3?“ sonfiicig
`Sf an timmef‘,
`
`{Signm‘wm $331853“ 0:: 3%: F5:21.59 24mg 33;:ng x}
`
`m;
`
`
`ata}.‘W.
`"i
`
`,WWW/ma
`
`mime.I
`
`
`
`am?“
`
` N
`x“
`.
`REELfiéfi353i» AME: 0425
`
`‘
`
`SRMT 2103 - Pg. 4
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01 129
`
`SRMT 2103 - Pg. 4
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01129
`
`
`
`LN WERE-SS TEiEREGF, Assigmr and A5sigaxe§ have gamad {Emir mspactivs £3313};
`authorized ei‘ficm to enema ihis A‘sxigmnem 333 ai‘ the Effective Date.
`
`33313333 Rggis Mahawk Tribe:
`
`Miergam Sam 3
`
` 133*MW
`
`3
`
`Names: Eria Thampxm
`
`Name: A Rfibfifi DFBai'iey
`
`Title: Tyibai Chief
`
`“Mia:
`
`Frzfisidezfl
`
`
`
`3833333333: Sawfly Cm}:
`
`T3316: Tribai Chief
`
`Name: Michaei (333333332333
`
`“rifle: Tribal Chief
`
`33‘3333;3333’5 3333333 333 3333‘:3: 3331333333 33333333333“ (itsw‘mfis3‘23 gig:{?§?5??€‘§3!
`i3?
`
`
`
`REEL.“343332
`AME: 0426
`
`SRMT 2103 - Pg. 5
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01 129
`
`SRMT 2103 - Pg. 5
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01129
`
`
`
`.émigmm .33 n~ T3233 Paiggga:
`
`
`
`Ahamimafi
`23333213122302.3222:
`
`
`
`
`
`
`
`
`................................................................................................................
`.
`...._._._..
`
`‘”
`' S-mmssfimmmrg”3
`3
`
`5,354,?.39
`17~RE8V~1994
`
`......i
`5 §33 33:10?
`3233-33333433538
`3
`
`
` {BnNfiv-EGQE
`
`63‘3???4533“
`2;:W33“233257332323
`
`
`
`2:21:25“? 272
`
`
`:64’351’36
`32.32323322223233333
`2.33.223223339” 3
`
`
`
`mnmgnm
`23—33222-2222242
`2332;327:3228
`
`iénAug-Em 3
`
`
`
`3 {34S{34%
`
`
`\,§§S.§3G
`23,3252 8323
`(32222122323232
`3
`33233922424233
`
`
`
`’33 «Max:333 3 4”“4..-
`23.2.22: 391S2«¥e3>«2§36314i22233?3 3
`
`
`..-..-
`3 ””33””
`33
`3
`3229222325
`3374321155.‘3333
`3
`
`.
`_
`...3...
`________________
`
`_finnAug.333 13
`3
`1319618133?
`,
`
`:
`‘7 Augn’33333
`
`....53......
`
`
`”E‘ssnii'ig”
`
`
` 233,302 2 2:223
`
`
`_ 3333422432225
`_
`..
`ahandoaad
`
`323233323” 33
`
`Lamaze vawmml
`3.322,pnzg3m
`
`
`
`2323223225’:
`21LAagn23.304
`Abgimiam‘d
`
`
`
`
`
`
`323.293.323.054
`232332222332222
`iSnNm‘ngfiiMi
`
`21.3439,
`‘
`13.0033.
`
`
`
`
`
`33?».3‘3wé333)”
`Abamiutmi
`n
`3
`31f§§3§€35
`
`........--.....-.-...-?--..W---...-...--£................................ ...........“..............---..---.
`...................
`
`
`
`
` .W.--W.fi-
`3
`234222—3949
`.
`32322222232233.3222
`.
`-
`3E5§€3£32
`
`
`
` 23.322233
`7 153 3335“”
`39259238333
`3&ch—
`
`?833232.355”
`23242233333232;
`22-34394333” '
`
`
`
`“2333.33.33”
`222223252233
`
`
`
`
`
`
`
` 33 322222222313
`22023
`W33..
`
`
`
`.
`384312—2332 i 2";
`
`m..._.‘.‘umum.5..ww_w-.....WM..........3
` “3' $335,479
`
`3312134233335
`232222.523:
`”3 33' 3 8 E .,
`
`
`
`
`
`
`
`
`”3%”222355
`
`__3MLRHZ
`33/857.33'
`3
`3k
`
`‘
`‘
`‘
`‘
`.nifiexz‘émmz‘ .33 3‘23 Shaw Farm P33553233: 23.325333392223322“3332;362:333;.23:
`
`
`23°
`5
`L ’
`
`.-‘ Rafi ”mi {.33
`3
`3 f3».
`3
`‘
`z
`
`.-
`
`Agm
`:”U43552 FRAME: 0427
`
`RE
`
`SRMT 2103 - Pg. 6
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01 129
`
`SRMT 2103 - Pg. 6
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01129
`
`
`
` E
`
`
`
`“““
`
`“mm“mum.“
`“.344“
`
`
`
`E11131; 13.1113
`1
`3131123 3 63113333533135
`,
`"3321::‘
`.............
`
`
`3313331113
`8575.133"
`1.119411,6$3
`15.31113~21ij
`
`
`
`
`
`131333333“: 331332313
`
`1 3Ma:2015
`
`
`
`335336:
`111135343
`j “1713131333
`
`
`
`
`11331423 E
`33313334331
`133633333"
`
`
`7".§§?:T9.1..1...1W1Ff: 3323
`E3613136311117
`
`
`111391133 1333132313
`
`
`
`
`13635,731 23133.231
`-
`
`
`
`E33133}
`US
`;
`“313363313‘”1 2133333333
`
`
`
`
`m7"
`‘391111861
`_13.2361333wa 231332303
`
`
`
`m1E338631
`‘
`
`
`
`
`1393:9,???)
`93981131de
`
`
`
`
`13!95£§,8<19
`3331;333:1311
`
`Abanéflnfid
`
`
`
`
`11.131135111116311
`
` ‘
`
`
`
`
`
`331131113
`131333333
`241632313
`'
`13:35;5335
`:1.312133633
`3332136ng
`
`
`
`
` - -_...
`«4.4.4.144
`
`
`
`1139512111 vaésiaz331
`1
`.
`.
`3315333133W“"
`
`3:1613333““1W13331,13:
`
`
`
`Afimfiomd
`
`
`33332131011561
`
`
`Pending
`391313-1311
`
`..~
`. M33AMWW
`
`331313213:239
`251111291351
`iE19336 vai§m§m§
`
`WWWMWNWM;
`}
`
`--
`’
`61153291196
`2’3Qciuififié
`flawed E’mvigimmi
`1
`““"m'"
`"m“!
`
`
`
`
`E63933:
`“1333163013 .
`_
`femiing
`
`:133663311
`“13133111101363
`
`
`
`
` " 51'169196 11393611 11311323613331
`
`1‘61"?”1 95"
`
` W .............‘L“W
`E'E3.6132313 1
`
`
`
`RE “”64353fi5RAME: 0428
`
`SRMT 2103 - Pg. 7
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01 129
`
`SRMT 2103 - Pg. 7
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01129
`
`
`
`
`...........
`ril
`1
`1
`=
`\
`
`E33122: 3mg '
`gERfiM. N9.
`FSLEN'G 3&3’3
`$TATE;S s" 1:.Gmfi‘N’E‘E
`E1I
`
`.......,..
`“mm...“mw
`.
`.»
`
`fififfififiwfir 4 1212523323009
`E
`lapsed vaiskmai
`
`
`
`
`WW WW WWWWWWWWWWWWWWWWWWWWWWWWWWWW 25WWLagsggMWWW
`Si!347,851
`
`
`
`132‘ 123,754
`25Via?29H
`Ahanmnefi
`3225223155: Z’LEEE2314
`
`
`
`Fmfiing
`
`
`Abandened
`
`
`2;;Eiiggj‘"“’“"
`
`
`
`.
`
`. ESMm;3814
`
`
`
`
`:23Feb.2325
`
`Abanéemsd
`Akanéégeg
`Pegging
`
`
`
`
`
`REEL: 0435
`
`FRA E: 0429
`
`RECORDED: 09/08/2017
`
`SRMT 2103 - Pg. 8
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01 129
`
`SRMT 2103 - Pg. 8
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01129
`
`